113 related articles for article (PubMed ID: 6117231)
1. [Humoral and cellular immunity in patients with cancer of the esophagus. Effects of nutritional preparation].
Martin C; Auffray JP; Barthelemy A; Fulachier V; Fuentes P; Gouin F
Ann Anesthesiol Fr; 1981; 22(3):259-64. PubMed ID: 6117231
[No Abstract] [Full Text] [Related]
2. [Evaluation of the cellular and humoral immune response in patients with cancer of the esophagus. Preliminary results in 18 cases].
Zerilli M; Luzi G; Moraldi A; Mezzaroma I; Iascone C; D'Offizi GP; Fratazzi C; Accordino M; Cavallini M
Minerva Chir; 1988 Jan; 43(1-2):41-4. PubMed ID: 3362392
[No Abstract] [Full Text] [Related]
3. [Preoperative exploration of the humoral and cellular immunity of patients with esophageal cancer].
Gouin F; Auffray JP; Martin C; Plaisant E; Fuentes P
Nouv Presse Med; 1980 Nov; 9(42):3187. PubMed ID: 7443477
[No Abstract] [Full Text] [Related]
4. [Standard for determining the preoperative nutritional condition and significance of preoperative nutritional supplement in patients with esophageal cancer].
Tanaka M; Kako N; Tokuchi I; Izumiyama T; Chiba K
Geka Chiryo; 1971 May; 24(5):513-21. PubMed ID: 4996900
[No Abstract] [Full Text] [Related]
5. Preoperative nutritional status and postoperative outcome in patients with carcinoma of the esophagus.
Sitges-Serra A; Minguella JL; Rafecas A; Oms L; Valverde J; Jaurrieta E
Nutrition; 1990; 6(2):167-8. PubMed ID: 2134530
[No Abstract] [Full Text] [Related]
6. [Changes in humoral and cellular immunity in patients operated on due to esophageal cancer].
Szczesny T; Słotwiński R; Szczesny G
Pol Merkur Lekarski; 2005 Apr; 18(106):478-82. PubMed ID: 16161939
[TBL] [Abstract][Full Text] [Related]
7. [Effects of preoperative local administration of BRM on cellular immunity and prognosis of patients with esophageal cancer].
Tanaka Y; Miyama T; Suda Y; Fujita K; Takubo K
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1780-3. PubMed ID: 1877817
[TBL] [Abstract][Full Text] [Related]
8. [Nutritional, respiratory and immunologic status following excision of cancer of the esophagus. Influence on the postoperative course].
Delalande JP; Lozac'h P; Le Page JL; Le Bos-Monnot M; Perramant M
Cah Anesthesiol; 1986; 34(5):367-72. PubMed ID: 3779477
[No Abstract] [Full Text] [Related]
9. [Prognostic significance of cellular immunity in surgical treatment of esophageal cancer].
Polkowski W; Dabrowski A; Wallner G; Zinkiewicz K; Misiuna P
Wiad Lek; 1997; 50 Suppl 1 Pt 1():348-51. PubMed ID: 9446382
[TBL] [Abstract][Full Text] [Related]
10. [Effects of different anesthetic and analgesic protocols on cellular immune function and stress hormone level in patients undergoing lobectomy for esophagus cancer].
Xing CY; Wu MY; Fan HP
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):284-7. PubMed ID: 20159701
[TBL] [Abstract][Full Text] [Related]
11. [Significance of skin tests in pre-operative assessment].
Perramant M; Perramant-Creach Y; Delalande JP; Miossec A; Egreteau JP
Ann Anesthesiol Fr; 1981; 22(3):279-84. PubMed ID: 6117234
[TBL] [Abstract][Full Text] [Related]
12. [The host-defense index predicting the risk of operative mortality in esophageal cancer patients].
Saito T; Zeze K; Kuwahara A; Hirao E; Shimoda K; Kawano K; Kobayashi M
Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):21-9. PubMed ID: 2452342
[TBL] [Abstract][Full Text] [Related]
13. [Histological effect and prognosis after preoperative chemotherapy in esophageal cancer].
Ohara M; Ishihara K; Abe T; Yamazaki S; Miura T; Tanabe Y; Kusano M; Okayasu T; Hosokawa M; Fujita M
Rinsho Byori; 1995 Mar; 43(3):238-46. PubMed ID: 7745829
[TBL] [Abstract][Full Text] [Related]
14. Tumor immune systems in esophageal cancer with special reference to heat-shock protein 70 and humoral immunity.
Nakajima M; Kato H; Miyazaki T; Fukuchi M; Masuda N; Fukai Y; Sohda M; Ahmad F; Kuwano H
Anticancer Res; 2009 May; 29(5):1595-606. PubMed ID: 19443372
[TBL] [Abstract][Full Text] [Related]
15. [Various cellular immunity indices in patients with esophageal cancer].
Tsoĭ AI; Chichua NA; Kolycheva NI
Vopr Onkol; 1979; 25(12):15-8. PubMed ID: 516576
[TBL] [Abstract][Full Text] [Related]
16. [Cellular immunity in patients with esophageal and gastric tumors in various stages].
Horváth OP; Petri I; Kaiser G; Imre J; Petri G
Orv Hetil; 1981 Jun; 122(26):1567-72. PubMed ID: 7290665
[No Abstract] [Full Text] [Related]
17. Nutritional assessment in patients with squamous cell carcinoma of the esophagus.
Gurski RR; Schirmer CC; Rosa AR; Brentano L
Hepatogastroenterology; 2003; 50(54):1943-7. PubMed ID: 14696438
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of various immunological indicators after radiation treatment of patients with cancer of the lungs and esophagus].
Ogorodnikova SG; Sherban' EI; Gerasimiak VG
Lab Delo; 1986; (6):355-7. PubMed ID: 2427784
[No Abstract] [Full Text] [Related]
19. [Should undernutrition be corrected prior to surgery in patients with cancer of the oesophagus or cardia? (author's transl)].
Belghiti J; Langonnet F; Wessely JY; Fekete F
Nouv Presse Med; 1981 Jun; 10(27):2273-9. PubMed ID: 6791126
[TBL] [Abstract][Full Text] [Related]
20. NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer.
Akcakanat A; Kanda T; Koyama Y; Watanabe M; Kimura E; Yoshida Y; Komukai S; Nakagawa S; Odani S; Fujii H; Hatakeyama K
Cancer Chemother Pharmacol; 2004 Jul; 54(1):95-100. PubMed ID: 15118836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
